COVID-19 vaccination induces long-lasting antibody B-cell responses, researchers find

Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of 113 health care workers in Catalonia who were followed for three years. The study, led by ISGlobal in collaboration with the Fundación Privada Daniel Bravo Andreu (FPDBA) and published in Cell Reports, also shows that exposure to the virus prior to vaccination differentially imprints the immune systems without compromising the quality of the antibody response.
Read More

Successful therapy confirmed for newborns with fatal metabolic disorder MoCD type A

The drug fosdenopterin/rcPMP considerably improves the chances of survival and developmental progress in infants with molybdenum cofactor deficiency (MoCD type A), a rare and life-threatening genetic condition causing an inborn error in metabolism. This was shown in a clinical study recently published by an international research team led by Professor Dr. Günter Schwarz from the Institute of Biochemistry at the University of Cologne.
Read More
Top